Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Clinical trial NCT05279235 · TERMINATED

Trial details

NCT number: NCT05279235
Sponsor: Shanghai Vinnerna Biosciences Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe COVID-19

Start date: 2022-03-14
Primary completion: 2022-12-15
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.